26,686 Shares in agilon health, inc. (NYSE:AGL) Purchased by Wealthfront Advisers LLC

Wealthfront Advisers LLC bought a new position in shares of agilon health, inc. (NYSE:AGLFree Report) during the 4th quarter, Holdings Channel reports. The institutional investor bought 26,686 shares of the company’s stock, valued at approximately $51,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Oak Thistle LLC bought a new stake in agilon health in the fourth quarter valued at approximately $25,000. Ieq Capital LLC bought a new stake in agilon health in the fourth quarter valued at approximately $26,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in agilon health in the third quarter valued at approximately $28,000. Raymond James Financial Inc. bought a new stake in agilon health in the fourth quarter valued at approximately $33,000. Finally, Symphony Financial Services Inc. raised its stake in agilon health by 44.3% in the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock valued at $44,000 after buying an additional 7,058 shares during the period.

Analyst Upgrades and Downgrades

AGL has been the topic of several research analyst reports. Needham & Company LLC restated a “hold” rating on shares of agilon health in a research note on Wednesday, February 26th. Sanford C. Bernstein upped their target price on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research report on Wednesday, January 15th. Citigroup raised agilon health from a “sell” rating to a “neutral” rating and upped their target price for the company from $1.75 to $2.25 in a research report on Friday, January 10th. Royal Bank of Canada upped their target price on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research report on Wednesday, February 26th. Finally, Stifel Nicolaus upped their target price on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research report on Wednesday, February 26th. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $3.95.

View Our Latest Analysis on agilon health

agilon health Trading Up 3.2 %

Shares of NYSE:AGL opened at $4.34 on Wednesday. The business’s 50 day simple moving average is $3.39 and its 200 day simple moving average is $2.93. The company has a market capitalization of $1.79 billion, a P/E ratio of -4.61 and a beta of 0.67. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $7.73. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

About agilon health

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGLFree Report).

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.